Dear Colleagues and Friends,

It is with great pleasure that we invite you to partake in the 1st  CannX Brazil – The International Congress of Cannabinoid Medicine, to be held on November 12th to 14th 2018, at the Centro de Convenções Rebouças, in São Paulo/Brazil.
From 1975 to 1982, a partnership between the Israeli research group lead by Raphael Mechoulam and the Brazilian team lead by Elisaldo Carlini yielded five articles revealing to the world the powerful anti-epileptic properties of cannabidiol. Nowadays, thousands of epileptic people around the world are enjoying the benefits of those pioneering studies and many more are having their suffering significantly mitigated by the growing number of medicinal applications for Cannabis and cannabinoids.

Brazil is a Latin America´s regional power with more than two hundred million citizens. During the second semester of 2018, the Brazilian government is expected to publish the rules that will regulate local production, distribution, research and medicinal use of cannabis and its derivatives. This step has been urgently expected by thousands of patients for whom cannabinoids represent hope for a new, longer and much better life.

In this context, about four decades later, Israelis and Brazilians are joining efforts again to help improve in Brazil and Latin America the knowledge about this ancient, yet revolutionary medicine. The first step in this partnership will be the realization of the 1st CannX Brazill: The International Congress of Cannabinoid Medicine.

This meeting will bring together some of the most important leaders in in the research of cannabinoid medicine from Israel and from around the world. It will include the participations of leading experts from Brazil and Latin America, as well as local authorities. This will contribute both regionally and globally to improve even more the growing scientific connection in the field.

The congress focus will be both on research and clinical experiences – with special emphasis on the latter one. Some of the topics covered will include the homeostatic role of the endocannabinoid system and the use of Cannabis and cannabinoids in clinical practice for the treatment of pain, cancer, autism, epilepsy and for the integrative care of the elderly.

Therefore, we invite you to take part in this effort and help the community to raise awareness to the potential benefits of cannabis and/or cannabinoids to the life of patients with epilepsy, cancer and other diseases that affect so many throughout the world.

 With my best regards,
Renato Malcher-Lopes
Congress Chairman - 1st CannX Brazil - International Congress for Cannabinoid Medicines

Invited Speakers

Scientific Program

Consult the complete schedule of lectures and courses available.



Don't worry, let's take care of it for you!


Event Venue

Rebouças Convention Center

Operating for more than 34 years, Centro de Convençoes Rebouças (Rebouças Convention Center) specializes in leasing spaces for events. It has 17 environments with air-conditioning that can accommodate up to 2,300 participants. You can easily reach Centro de Convençoes Rebouças through the following avenues: Avenida Paulista, Avenida Rebouças and Avenida Doutor Arnaldo – next to Clinicas Metro Station.

Av. Rebouças, 600 | 05402-000 | São Paulo | SP

Promoted By

Tourism Agency

Golden Sponsor
Silver Sponsor